Metabolic syndrome

Medicine

Volumn 34, Issue 12, 2006, Pages 536-542

  Han, T S ^a,b   Lean, M E J ^a,b  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

cardiovascular disease; dyslipidaemia; hyperglycaemia; metabolic syndrome; weight

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTIOBESITY AGENT; FLUOXETINE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; RIMONABANT; SEROTONIN AGONIST; SIBUTRAMINE; TETRAHYDROLIPSTATIN; TRIACYLGLYCEROL;

BODY FAT DISTRIBUTION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COMORBIDITY; DIET RESTRICTION; DRUG MECHANISM; DYSLIPIDEMIA; EXERCISE; GENETIC SUSCEPTIBILITY; HYPERGLYCEMIA; HYPERTENSION; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; PHENOTYPE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN; WEIGHT REDUCTION;

EID: 33845401029     PISSN: 13573039     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.mpmed.2006.09.012     Document Type: Review

References (5)

1. Kannel W.B., McGee D., and Gordon T. A general cardiovascular risk profile: the Framingham Study. Am J Cardiol 38 (1976) 46-51
2. Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
3. International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome [article online]. www.idf.org
4. Barker D.J.P. Fetal and infant origins of adult disease (1992), BMJ Publishing, London
5. Han T.S., Sattar N., Williams K., Gonzalez-Villalpando C., Lean M.E., and Haffner S.M. Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study. Diabetes care 25 (2002) 2016-2021